PLATINUM2023

New York Blood Center, Inc.

LEADING INNOVATION • SAVING LIVES • CONNECTING COMMUNITIES

aka NYBC   |   New York, NY   |  www.nybc.org

Mission

New York Blood Center Enterprises (NYBCe) is a dynamic and robust organization whose capabilities far exceed collecting blood. NYBCe has fulfilled its four-part mission since 1964: To provide high-quality blood products & stem cell services, conduct innovative research, develop new products and technologies that make a humanitarian impact, and train the next generation of industry leaders for generations to come. Today, our mission remains the same as we have amplified our life-saving work in order to serve communities and 75 million patients and 500 hospitals in the Tri-State area (NY, NJ, CT), Mid-Atlantic area (PA, DE, MD, VA), Missouri, Kansas, Minnesota, Nebraska, Rhode Island, and Southern New England.

Ruling year info

1961

President and Chief Executive Officer

Dr. Christopher D. Hillyer MD

Main address

310 E 67th Street

New York, NY 10065 USA

Show more contact info

EIN

13-1949477

NTEE code info

Blood Supply Related (E61)

AIDS (H81)

Medical Specialty Research (H90)

IRS filing requirement

This organization is required to file an IRS Form 990 or 990-EZ.

Sign in or create an account to view Form(s) 990 for 2022, 2021 and 2021.
Register now

Communication

Blog

Programs and results

What we aim to solve

SOURCE: Self-reported by organization

Our innovative blood operations and manufacturing practices establish New York Blood Center Enterprises (NYBCe) as a leading Center of Excellence in blood product and service delivery. We are dedicated to providing our customers with the highest quality blood products and services. We proudly serve as a vital community lifeline dedicated to helping patients and advancing global public health by: - Providing the highest quality blood and stem cell products and related medical and consultative services to hospitals and patients, primarily in the greater New York metropolitan area. - Conducting the highest quality, novel, and innovative research in the fields of hematology, blood banking, transfusion medicine, and cellular therapies, thus advancing these fields and positively impacting public health. - Developing products, technologies, and services in the fields of hematology, blood banking, transfusion medicine, and cellular therapies with the potential to have world.

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Education

NYBCe is committed to providing convenient and quality educational content for technologists, residents/fellows, students, and anyone interested in blood banking and transfusion medicine.

Population(s) Served

NYBC is one of the largest community-based, non-profit blood collection and distribution organizations in the United States. Our innovative blood operations and manufacturing practices establish New York Blood Center as a leading Center of Excellence in blood product and service delivery. We are dedicated to providing the highest quality blood products and services to our customers.

Our divisions include:
- Blood Bank of Delmarva
- Community Blood Center
- Innovative Blood Resources
- Memorial Blood Centers
- Nebraska Community Blood Bank
- New York Bood Center
- New Jersey Blood Services
- Rhode Island Blood Center
- Connecticut Blood Center

Population(s) Served

Established in 1964, Lindsley F. Kimball Research Institute (LFKRI) is the research branch of New York Blood Center Enterprises (NYBCe). LFKRI at NYBCe is one of the world’s preeminent blood research organizations conducting foundational, epidemiologic, and clinical research. Wholly focused on and unique in our ability to translate hematology insights into better health, we have assembled a prestigious team of investigators recognized globally for their innovative ideas and quality research.

Our deep exploration into and understanding of the mechanisms underlying blood-related diseases has resulted in tangible benefits for patients. Our investigators have discovered and licensed novel blood-related products, techniques, therapies, and diagnostics that have been developed and commercialized by NYBCe and our many collaborators.

Population(s) Served

Comprehensive Cell Solutions (CCS) is a cell therapy development and manufacturing organization focused on cell sourcing, process development, cGMP manufacturing, fill/finish, and cryo-preservation. For more than 20 years, CCS has been pioneering advances in the research, development, and manufacture of cellular therapies.

Population(s) Served

Where we work

Our results

SOURCE: Self-reported by organization

How does this organization measure their results? It's a hard question but an important one.

Number of blood donors

This metric is no longer tracked.
Totals By Year
Related Program

Blood Products and Services

Type of Metric

Input - describing resources we use

Direction of Success

Increasing

Number of Hospitals served

This metric is no longer tracked.
Totals By Year
Related Program

Blood Products and Services

Type of Metric

Output - describing our activities and reach

Direction of Success

Increasing

Our Sustainable Development Goals

SOURCE: Self-reported by organization

Learn more about Sustainable Development Goals.

Goals & Strategy

SOURCE: Self-reported by organization

Learn about the organization's key goals, strategies, capabilities, and progress.

Charting impact

Four powerful questions that require reflection about what really matters - results.

Our innovative blood operations and manufacturing practices establish New York Blood Center Enterprises (NYBCe) as a leading Center of Excellence in blood product and service delivery. We are dedicated to providing the highest quality blood products and services to our customers.

NYBCe also provides Advanced Laboratory Testing, Clinical Services, Hemophilia Services, and Transfusion Medicine Services.

NYBCe trains the next generation of leaders in the field of blood banking and transfusion medicine and is committed to providing convenient and quality educational content for technologists, residents/fellows, students, and anyone interested in blood banking and transfusion medicine.

Established in 1964, Lindsley F. Kimball Research Institute (LFKRI) is the research branch of NYBCe focused on our ability to translate hematology insights into better health.

We provide blood products and services including:

- Red Blood Cells
- Plasma Products
- Platelet Products
- Frozen Blood and Washed Products
- Whole Blood
- Granulocytes
- Autologous and Directed Blood Donation
- Hematopoietic Stem Cell Therapy
- Products for Research

Unparalleled Expertise in Advanced Laboratory Testing - NYBCe’s world-renowned laboratories help medical professionals around the world solve problems related to patient antibodies, blood typing, antigens, and much more.

Clinical Services - We provide services to many hospitals. Upon request, our highly trained staff can travel to your facility in the New York tri-state area to perform Cell Salvage and Autologous Platelet-rich Plasma/Bone Marrow concentrate procedures.

Hemophilia Services - NYBC has partnered with the Hemophilia Services Consortium, Inc., a cooperative hospital services organization dedicated to people with bleeding disorders, to provide pharmacy services to patients enrolled in select Hemophilia Treatment Centers (HTCs).

Transfusion Medicine Services - NYBC’s dedicated professionals provide a wide range of consultative services in hospitals and through special products and services to patients with bleeding disorders.

NYBC is one of the largest community-based, non-profit blood collection and distribution organizations in the United States. Our innovative blood operations and manufacturing practices establish New York Blood Center as a leading Center of Excellence in blood product and service delivery. We are dedicated to providing the highest quality blood products and services to our customers.

Our divisions include:
- Blood Bank of Delmarva
- Community Blood Center
- Innovative Blood Resources
- Memorial Blood Centers
- Nebraska Community Blood Bank
- New York Bood Center
- New Jersey Blood Services
- Rhode Island Blood Center
- Connecticut Blood Center

The Lindsley F. Kimball Research Institute (LFKRI) is the research branch of NYBCe and one of the world’s preeminent blood research organizations conducting foundational, epidemiologic, and clinical research. Wholly focused on and unique in our ability to translate hematology insights into better health with a prestigious team of investigators recognized globally for their innovative ideas and quality research.

NYBCe collects 1 million blood products annually and collects 4,000 blood donations a day, serving over 600 hospitals.

Our deep exploration into and understanding of the mechanisms underlying blood-related diseases has resulted in tangible benefits for patients. Our investigators have discovered and licensed novel blood-related products, techniques, therapies, and diagnostics that have been developed and commercialized by NYBCe and our many collaborators.

The LFKRI research team has published over 4,000 scholarly articles and created state-of-the-art research platforms in our cutting-edge facilities. As an independent, nonprofit entity, we offer an environment distinct from academic and corporate settings, providing career and undergraduate summer internship opportunities for growth and scientific leadership.

Financials

New York Blood Center, Inc.
lock

Unlock financial insights by subscribing to our monthly plan.

Subscribe

Unlock nonprofit financial insights that will help you make more informed decisions. Try our monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights?
Learn more about GuideStar Pro.

Operations

The people, governance practices, and partners that make the organization tick.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

New York Blood Center, Inc.

Board of directors
as of 09/14/2023
SOURCE: Self-reported by organization
Board chair

Marc Kramer, Esq.

William W. Crouse

HealthCareVentures LLC

Philip Falivene

Bank of New York Mellon

Owen Garrick

Bridge Clinical Research

Christopher D. Hillyer

New York Blood Center

Marc Kramer

Aaron R. Marcu

Freshfields Bruckhaus Deringer US LLP

Mark Schmidtlein

Robert A. Schwartz

SS&C GlobeOp

David Tendler

Tendler Beretz LLC

Stephen D. Wurtzler

Avery August

Cornell University

David Driscoll

John Ferretti

Ariel Fishman

Fordham University

Peter Lopez

NYU School of Medicine

Theresa Ragozine

John Rosenthal

Brighthouse Financial, Inc.

Board leadership practices

SOURCE: Self-reported by organization

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.

  • Board orientation and education
    Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? No
  • CEO oversight
    Has the board conducted a formal, written assessment of the chief executive within the past year ? No
  • Ethics and transparency
    Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? No
  • Board composition
    Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? No
  • Board performance
    Has the board conducted a formal, written self-assessment of its performance within the past three years? No

Organizational demographics

SOURCE: Self-reported; last updated 3/2/2021

Who works and leads organizations that serve our diverse communities? Candid partnered with CHANGE Philanthropy on this demographic section.

Leadership

The organization's leader identifies as:

Gender identity
Male

Race & ethnicity

No data

Gender identity

No data

Transgender Identity

No data

Sexual orientation

No data

Disability

No data